Latest news
8 December 2010
Spirit Pharmaceuticals joins GMiA
The Generic Medicines Industry Association is pleased to announce that Spirit Pharmaceuticals has joined the association. Spirit Pharmaceuticals is a major supplier of prescription pharmaceuticals to the Australian market.
In 2004 Spirit received its first Therapeutic Goods Administration (TGA) approval. As of 2010, Spirit has over 20 products approved by the Australian TGA, and another 15 products under evaluation.
Spirit Pharmaceuticals is headquartered in the Sydney CBD and has offices in Melbourne and Brisbane.
The Generic Medicines Industry Association (GMiA) is the national association representing companies that manufacture, supply and export generic medicines. The generic medicines sector is a high value-add sector delivering significant benefits to the Australian public by way of affordable medicines and high skilled jobs.
Contact: Kate Lynch 0432 500 308
|
